Ergoferon Increases IL-2 Production by Activated Lymphocytes
- Авторлар: Kanareikina M.1, Alinkina E.1, Petrova A.1, Emel’yanova A.1, Gorbunov E.1, Tarasov S.2
-
Мекемелер:
- Materia Medica Holding Research-and-Production Company, Research Institute of General Pathology and Pathophysiology
- Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathophysiology, Research Institute of General Pathology and Pathophysiology
- Шығарылым: Том 166, № 6 (2019)
- Беттер: 744-746
- Бөлім: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/241330
- DOI: https://doi.org/10.1007/s10517-019-04431-1
- ID: 241330
Дәйексөз келтіру
Аннотация
We studied the effects of Ergoferon on the production of antiviral cytokine IL-2 by type 1 CD4+T cells. Preincubation of Jurkat cells with Ergoferon increased IL-2 secretion by these cells after stimulation with phorbol 12-myristate 13-acetate/ionomycine in comparison with the placebo group. The data prove that Ergoferon is capable of activating cell cascades involved in the realization of the antiviral immune response.
Авторлар туралы
M. Kanareikina
Materia Medica Holding Research-and-Production Company, Research Institute of General Pathology and Pathophysiology
Хат алмасуға жауапты Автор.
Email: rad@materiamedica.ru
Ресей, Moscow
E. Alinkina
Materia Medica Holding Research-and-Production Company, Research Institute of General Pathology and Pathophysiology
Email: rad@materiamedica.ru
Ресей, Moscow
A. Petrova
Materia Medica Holding Research-and-Production Company, Research Institute of General Pathology and Pathophysiology
Email: rad@materiamedica.ru
Ресей, Moscow
A. Emel’yanova
Materia Medica Holding Research-and-Production Company, Research Institute of General Pathology and Pathophysiology
Email: rad@materiamedica.ru
Ресей, Moscow
E. Gorbunov
Materia Medica Holding Research-and-Production Company, Research Institute of General Pathology and Pathophysiology
Email: rad@materiamedica.ru
Ресей, Moscow
S. Tarasov
Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathophysiology, Research Institute of General Pathology and Pathophysiology
Email: rad@materiamedica.ru
Ресей, Moscow